Correlation Analysis between Gut Microbiota and Metabolites in Children with Systemic Lupus Erythematosus

J Immunol Res. 2021 Jul 23:2021:5579608. doi: 10.1155/2021/5579608. eCollection 2021.

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune-mediated diffuse connective tissue disease characterized by immune inflammation with an unclear aetiology and pathogenesis. This work profiled the intestinal flora and faecal metabolome of patients with SLE using 16S RNA sequencing and gas chromatography-mass spectrometry (GC-MS). We identified unchanged alpha diversity and partially altered beta diversity of the intestinal flora. Another important finding was the increase in Proteobacteria and Enterobacteriales and the decrease in Ruminococcaceae among SLE patients. For metabolites, amino acids and short-chain fatty acids were enriched when long-chain fatty acids were downregulated in SLE faecal samples. KEGG analysis showed the significance of the protein digestion and absorption pathway, and association analysis revealed the key role of 3-phenylpropanoic acid and Sphingomonas. Sphingomonas were reported to be less abundant in healthy periodontal sites of SLE patients than in those of HCs, indicating transmission of oral species to the gut. This study contributes to the understanding of the pathogenesis of SLE disease from the perspective of intestinal microorganisms, explains the pathogenesis of SLE, and serves as a basis for exploring potential treatments for the disease.

MeSH terms

  • Age Factors
  • Biomarkers
  • Case-Control Studies
  • Child
  • Disease Susceptibility*
  • Dysbiosis
  • Feces / microbiology
  • Female
  • Gas Chromatography-Mass Spectrometry / methods
  • Gastrointestinal Microbiome*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / etiology*
  • Lupus Erythematosus, Systemic / metabolism*
  • Lupus Erythematosus, Systemic / pathology
  • Male
  • Metabolome*
  • Metabolomics / methods
  • Metagenomics / methods

Substances

  • Biomarkers
  • Immunosuppressive Agents